The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza TM ) for adult patients with a rare condition ...
We still don’t know the full extent of layoffs at the FDA, though they are widespread. That could reduce oversight of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results